{"product_id":"harvard-breast-cancer-new-horizons-current-controversies-2025-videos-slides","title":"Harvard Breast Cancer: New Horizons, Current Controversies 2025 (Videos + Slides)","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\n\u003cp class=\"program-summary__summary intro-text\"\u003eAdvance your clinical expertise in breast oncology with this dynamic course offering the latest breakthroughs in diagnosis, treatment, and survivorship to elevate patient care across all stages of breast cancer.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv data-program-session=\"1493\" class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12\"\u003e\n\u003cdiv class=\"program-summary__highlights card-shadow\"\u003e\n\u003cdiv class=\"highlights__item highlights__format\"\u003e\n\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\n\u003ch4 class=\"program-overview__title\"\u003eOverview\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"program-overview__content cell initial-12 medium-7\"\u003e\n\u003cdiv class=\"wysiwyg\"\u003e\n\u003cp\u003eBreast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence, and clinical skills of health care professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses; and other clinicians involved in the care of breast cancer patients.\u003c\/p\u003e\n\u003cp\u003eThe two-day course is taught by clinical experts in medical oncology, surgical oncology, radiation oncology, and pathology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical applications. Course participants engage with the material through interactive learning formats, including group case discussions, question and answer sessions, and panel presentations. This interactive learning process assists healthcare professionals in integrating the latest evidence-based information on breast cancer screening, diagnosis, treatment, and long-term monitoring into their clinical practices.\u003c\/p\u003e\n\u003cp\u003eThis year, we will be again offering an in-person program as well as a livestream for those who still do not feel comfortable traveling to Boston. Continuing with the livestream allows participants to engage with our faculty from the convenience of their own community, be it in Boston or across the globe. This hybrid format worked very well last year and is appropriate given both the range of potential attendees and persistent uncertainty over travel and large group gatherings.\u003c\/p\u003e\n\u003cp\u003eThe timing of the course for summer 2025 is particularly fortuitous owing to the extraordinary progress happening in breast cancer. In the last two years, we have seen transformative breakthroughs in all types of breast cancer treatment:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFDA approval of novel antibody-drug conjugates for the treatment of advanced hormone receptor-positive, HER2-positive, and triple-negative breast cancer, with new data showing benefit of these agents in tumor types beyond their initial application.\u003c\/li\u003e\n\u003cli\u003eFDA approval of the first-in-class oral SERD elacestrant in hormone receptor-positive metastatic breast cancer, with companion diagnostic genomic testing for targetable ESR1 mutations.\u003c\/li\u003e\n\u003cli\u003eFDA approval of the AKT pathway inhibitor capivasertib in combination with fulvestrant for patients with hormone receptor-positive, PIK3CA\/AKT\/PTEN-mutant metastatic breast cancer and reported phase III data of another agent in this class (inavolisib).\u003c\/li\u003e\n\u003cli\u003eFDA approval of the CDK4\/6 inhibitor abemaciclib in high-risk, early-stage hormone receptor-positive breast cancer, and mature data showing compelling benefits including overall survival for this class of drugs in advanced breast cancer, as well as preliminary reports of a second agent in this class (ribociclib) with adjuvant efficacy.\u003c\/li\u003e\n\u003cli\u003eFDA approval of a novel antibody-drug conjugate for patients with a HER2-low metastatic breast cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eLearning Objectives\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eApply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced breast cancer.\u003c\/li\u003e\n\u003cli\u003eSelect appropriate risk assessment modalities, where applicable, and make evidence-based therapeutic selections for women who are candidates for neoadjuvant or adjuvant therapy and know the limitations of genomic testing.\u003c\/li\u003e\n\u003cli\u003eApply recent clinical data and expert recommendations to the management of women with breast cancer who are treated with mastectomy, including integration of surgical methods, breast reconstruction options, and post-mastectomy radiation if needed.\u003c\/li\u003e\n\u003cli\u003eAssess current practices regarding symptom management during active treatment and in survivorship and consider the needs for fertility and lifestyle counseling among patients with breast cancer and survivors and improve current practices if needed.\u003c\/li\u003e\n\u003cli\u003eEvaluate the genetic and personal risk factors of breast cancer and utilize appropriate genetic testing for hereditary breast cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"schedule__item-title-wrapper\" style=\"text-align: center;\"\u003e\n\u003ch2 data-end=\"200\" data-start=\"160\"\u003eSchedule\u003c\/h2\u003e\n\u003ch2 data-end=\"200\" data-start=\"160\"\u003e\u003cstrong data-end=\"198\" data-start=\"163\"\u003eDay 1 – Thursday, July 17, 2025\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"282\" data-start=\"201\"\u003e\u003cstrong data-end=\"211\" data-start=\"201\"\u003eTheme:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAdvances in Radiation Therapy, Pathology, and Breast Cancer Management\u003c\/p\u003e\n\u003chr data-end=\"287\" data-start=\"284\"\u003e\n\u003ch3 data-end=\"316\" data-start=\"289\"\u003e\u003cstrong data-end=\"314\" data-start=\"293\"\u003eWelcoming Remarks\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"372\" data-start=\"317\"\u003e\u003cstrong data-end=\"329\" data-start=\"317\"\u003eSpeaker:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eHarold Burstein\u003cbr data-end=\"348\" data-start=\"345\"\u003e\u003cstrong data-end=\"357\" data-start=\"348\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e8:00 – 8:15 am\u003c\/p\u003e\n\u003chr data-end=\"377\" data-start=\"374\"\u003e\n\u003ch3 data-end=\"418\" data-start=\"379\"\u003e\u003cstrong data-end=\"416\" data-start=\"383\"\u003eSession I: Radiation Oncology\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"1035\" data-start=\"420\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"500\" data-start=\"420\"\u003e\n\u003ctr data-end=\"500\" data-start=\"420\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"438\" data-start=\"420\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"486\" data-start=\"438\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"500\" data-start=\"486\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"1035\" data-start=\"582\"\u003e\n\u003ctr data-end=\"663\" data-start=\"582\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"600\" data-start=\"582\"\u003e8:15 – 8:35 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"648\" data-start=\"600\"\u003e50 Years of Radiation Therapy\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"663\" data-start=\"648\"\u003eAbram Recht\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"749\" data-start=\"664\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"682\" data-start=\"664\"\u003e8:35 – 8:55 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"735\" data-start=\"682\"\u003eStandard Radiation Therapy: The Long and the Short\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"749\" data-start=\"735\"\u003eJulia Wong\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"829\" data-start=\"750\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"768\" data-start=\"750\"\u003e8:55 – 9:15 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"816\" data-start=\"768\"\u003eThe Future of Breast Radiation Therapy\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"829\" data-start=\"816\"\u003eAtif Khan\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"914\" data-start=\"830\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"848\" data-start=\"830\"\u003e9:15 – 9:35 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"896\" data-start=\"848\"\u003eRadiopharmaceuticals\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"914\" data-start=\"896\"\u003eHeather Jacene\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1035\" data-start=\"915\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"933\" data-start=\"915\"\u003e9:35 – 9:50 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"981\" data-start=\"933\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1035\" data-start=\"981\"\u003eAbram Recht, Atif Khan, Julia Wong, Heather Jacene\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"1040\" data-start=\"1037\"\u003e\n\u003ch3 data-end=\"1073\" data-start=\"1042\"\u003e\u003cstrong data-end=\"1071\" data-start=\"1046\"\u003eSession II: Pathology\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"1519\" data-start=\"1075\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"1155\" data-start=\"1075\"\u003e\n\u003ctr data-end=\"1155\" data-start=\"1075\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"1093\" data-start=\"1075\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"1141\" data-start=\"1093\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"1155\" data-start=\"1141\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"1519\" data-start=\"1237\"\u003e\n\u003ctr data-end=\"1321\" data-start=\"1237\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1255\" data-start=\"1237\"\u003e9:50 – 10:10 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1303\" data-start=\"1255\"\u003eLobular Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1321\" data-start=\"1303\"\u003eStuart Schnitt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1415\" data-start=\"1322\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1341\" data-start=\"1322\"\u003e10:10 – 10:30 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1394\" data-start=\"1341\"\u003ectDNA: The Evolving Role for Molecular Diagnostics\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1415\" data-start=\"1394\"\u003eStefania Morganti\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1519\" data-start=\"1416\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1435\" data-start=\"1416\"\u003e10:30 – 10:45 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1482\" data-start=\"1435\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1519\" data-start=\"1482\"\u003eStuart Schnitt, Stefania Morganti\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"1524\" data-start=\"1521\"\u003e\n\u003ch3 data-end=\"1551\" data-start=\"1526\"\u003e\u003cstrong data-end=\"1549\" data-start=\"1530\"\u003eSpecial Lecture\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1714\" data-start=\"1552\"\u003e\u003cstrong data-end=\"1561\" data-start=\"1552\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e11:00 – 11:40 am\u003cbr data-end=\"1581\" data-start=\"1578\"\u003e\u003cstrong data-end=\"1596\" data-start=\"1581\"\u003eSpeaker(s):\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSydney Smith \u0026amp; Julie Bosworth\u003cbr data-end=\"1629\" data-start=\"1626\"\u003e\u003cstrong data-end=\"1639\" data-start=\"1629\"\u003eTopic:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eWhat's New in Supportive Care: Management of Gastrointestinal Side Effects\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"2073\" data-start=\"1716\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"1796\" data-start=\"1716\"\u003e\n\u003ctr data-end=\"1796\" data-start=\"1716\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"1734\" data-start=\"1716\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"1782\" data-start=\"1734\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"1796\" data-start=\"1782\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2073\" data-start=\"1878\"\u003e\n\u003ctr data-end=\"1960\" data-start=\"1878\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1897\" data-start=\"1878\"\u003e11:00 – 11:20 am\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1945\" data-start=\"1897\"\u003eEssentials of Germline Genetics\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1960\" data-start=\"1945\"\u003eJudy Garber\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2073\" data-start=\"1961\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1980\" data-start=\"1961\"\u003e11:20 – 11:40 am\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2028\" data-start=\"1980\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2073\" data-start=\"2028\"\u003eJulie Bosworth, Sydney Smith, Judy Garber\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2078\" data-start=\"2075\"\u003e\n\u003ch3 data-end=\"2121\" data-start=\"2080\"\u003e\u003cstrong data-end=\"2119\" data-start=\"2084\"\u003eSchwartz Rounds: A Complex Case\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2208\" data-start=\"2122\"\u003e\u003cstrong data-end=\"2134\" data-start=\"2122\"\u003eSpeaker:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAnn Partridge\u003cbr data-end=\"2151\" data-start=\"2148\"\u003e\u003cstrong data-end=\"2160\" data-start=\"2151\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e11:50 am – 12:20 pm\u003cbr data-end=\"2183\" data-start=\"2180\"\u003e\u003cstrong data-end=\"2191\" data-start=\"2183\"\u003eQ\u0026amp;A:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e12:20 – 12:30 pm\u003c\/p\u003e\n\u003chr data-end=\"2213\" data-start=\"2210\"\u003e\n\u003ch3 data-end=\"2257\" data-start=\"2215\"\u003e\u003cstrong data-end=\"2255\" data-start=\"2219\"\u003eTumor Board: Early Breast Cancer\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"2461\" data-start=\"2259\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"2291\" data-start=\"2259\"\u003e\n\u003ctr data-end=\"2291\" data-start=\"2259\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"2277\" data-start=\"2259\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"lg\" data-end=\"2291\" data-start=\"2277\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2461\" data-start=\"2325\"\u003e\n\u003ctr data-end=\"2461\" data-start=\"2325\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2343\" data-start=\"2325\"\u003e12:40 – 1:40 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"2461\" data-start=\"2343\"\u003eHarold Burstein, Faina Nakhlis, Julia Wong, Brittany Bychkovsky, Adrienne Waks, Filipa Lynce, Elizabeth Mittendorf\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2466\" data-start=\"2463\"\u003e\n\u003ch3 data-end=\"2518\" data-start=\"2468\"\u003e\u003cstrong data-end=\"2516\" data-start=\"2472\"\u003eSession III: HER2 Positive Breast Cancer\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"3082\" data-start=\"2520\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"2600\" data-start=\"2520\"\u003e\n\u003ctr data-end=\"2600\" data-start=\"2520\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"2538\" data-start=\"2520\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"2586\" data-start=\"2538\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"2600\" data-start=\"2586\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3082\" data-start=\"2682\"\u003e\n\u003ctr data-end=\"2777\" data-start=\"2682\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2700\" data-start=\"2682\"\u003e1:50 – 2:10 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2760\" data-start=\"2700\"\u003eNew Approaches in Early Stage HER2 Positive Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2777\" data-start=\"2760\"\u003eAdrienne Waks\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2878\" data-start=\"2778\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2796\" data-start=\"2778\"\u003e2:10 – 2:30 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2861\" data-start=\"2796\"\u003eThe Progress Continues: Late Stage HER2 Positive Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2878\" data-start=\"2861\"\u003eSarah Sammons\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2958\" data-start=\"2879\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2897\" data-start=\"2879\"\u003e2:30 – 2:50 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2945\" data-start=\"2897\"\u003eCan We Cure Metastatic Breast Cancer?\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2958\" data-start=\"2945\"\u003eNancy Lin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3082\" data-start=\"2959\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2977\" data-start=\"2959\"\u003e2:50 – 3:05 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3025\" data-start=\"2977\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3082\" data-start=\"3025\"\u003eSara Tolaney, Sarah Sammons, Nancy Lin, Adrienne Waks\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3087\" data-start=\"3084\"\u003e\n\u003ch3 data-end=\"3114\" data-start=\"3089\"\u003e\u003cstrong data-end=\"3112\" data-start=\"3093\"\u003eSpecial Lecture\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3222\" data-start=\"3115\"\u003e\u003cstrong data-end=\"3124\" data-start=\"3115\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e3:20 – 4:35 pm\u003cbr data-end=\"3142\" data-start=\"3139\"\u003e\u003cstrong data-end=\"3157\" data-start=\"3142\"\u003eSpeaker(s):\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eErica Warner, Filipa Lynce, Antonio Giordano, Jennifer Ligibel\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"3786\" data-start=\"3224\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"3304\" data-start=\"3224\"\u003e\n\u003ctr data-end=\"3304\" data-start=\"3224\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3242\" data-start=\"3224\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"lg\" data-end=\"3290\" data-start=\"3242\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3304\" data-start=\"3290\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3786\" data-start=\"3386\"\u003e\n\u003ctr data-end=\"3524\" data-start=\"3386\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3404\" data-start=\"3386\"\u003e3:20 – 3:45 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"3508\" data-start=\"3404\"\u003eRacial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3524\" data-start=\"3508\"\u003eErica Warner\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3608\" data-start=\"3525\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3543\" data-start=\"3525\"\u003e3:45 – 4:10 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"3592\" data-start=\"3543\"\u003eInflammatory Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3608\" data-start=\"3592\"\u003eFilipa Lynce\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3695\" data-start=\"3609\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3627\" data-start=\"3609\"\u003e4:10 – 4:35 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"3675\" data-start=\"3627\"\u003eEarly Drug Discovery in Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3695\" data-start=\"3675\"\u003eAntonio Giordano\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3786\" data-start=\"3696\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3714\" data-start=\"3696\"\u003e4:35 – 5:00 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"3766\" data-start=\"3714\"\u003eLifestyle\/Diet\/Exercise in Breast Cancer Patients\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3786\" data-start=\"3766\"\u003eJennifer Ligibel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3791\" data-start=\"3788\"\u003e\n\u003ch3 data-end=\"3812\" data-start=\"3793\"\u003e\u003cstrong data-end=\"3810\" data-start=\"3797\"\u003eReception\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3837\" data-start=\"3813\"\u003e\u003cstrong data-end=\"3822\" data-start=\"3813\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e5:00 – 6:00 pm\u003c\/p\u003e\n\u003chr data-end=\"3842\" data-start=\"3839\"\u003e\n\u003ch2 data-end=\"3882\" data-start=\"3844\"\u003e\u003cstrong data-end=\"3880\" data-start=\"3847\"\u003eDay 2 – Friday, July 18, 2025\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"3953\" data-start=\"3883\"\u003e\u003cstrong data-end=\"3893\" data-start=\"3883\"\u003eTheme:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSurgical Interventions and Advanced Breast Cancer Treatment\u003c\/p\u003e\n\u003chr data-end=\"3958\" data-start=\"3955\"\u003e\n\u003ch3 data-end=\"3989\" data-start=\"3960\"\u003e\u003cstrong data-end=\"3987\" data-start=\"3964\"\u003eSession IV: Surgery\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"4676\" data-start=\"3991\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"4071\" data-start=\"3991\"\u003e\n\u003ctr data-end=\"4071\" data-start=\"3991\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"4009\" data-start=\"3991\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"4057\" data-start=\"4009\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"4071\" data-start=\"4057\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4676\" data-start=\"4153\"\u003e\n\u003ctr data-end=\"4251\" data-start=\"4153\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4171\" data-start=\"4153\"\u003e8:00 – 8:20 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4233\" data-start=\"4171\"\u003eOncoplastic Reconstruction: Common Indications and Outcomes\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4251\" data-start=\"4233\"\u003eIndranil Sinha\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4356\" data-start=\"4252\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4270\" data-start=\"4252\"\u003e8:20 – 8:40 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4332\" data-start=\"4270\"\u003eThe Axilla After Neoadjuvant Therapy: How Much Is Too Much?\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4356\" data-start=\"4332\"\u003eElizabeth Mittendorf\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4438\" data-start=\"4357\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4375\" data-start=\"4357\"\u003e8:40 – 9:00 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4423\" data-start=\"4375\"\u003eImplications of the SOUND Trial\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4438\" data-start=\"4423\"\u003eOlga Kantor\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4524\" data-start=\"4439\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4457\" data-start=\"4439\"\u003e9:00 – 9:20 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4505\" data-start=\"4457\"\u003eCryoblation Instead of Surgery\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4524\" data-start=\"4505\"\u003eFrancys Verdial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4676\" data-start=\"4525\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4543\" data-start=\"4525\"\u003e9:20 – 9:35 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4591\" data-start=\"4543\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4676\" data-start=\"4591\"\u003eBarbara Smith, Indranil Sinha, Olga Kantor, Francys Verdial, Elizabeth Mittendorf\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4681\" data-start=\"4678\"\u003e\n\u003ch3 data-end=\"4767\" data-start=\"4683\"\u003e\u003cstrong data-end=\"4765\" data-start=\"4687\"\u003eSchlager Lecture: Immunotherapy in Early Breast Cancer: Today and Tomorrow\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"4820\" data-start=\"4768\"\u003e\u003cstrong data-end=\"4780\" data-start=\"4768\"\u003eSpeaker:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eMarleen Kok\u003cbr data-end=\"4795\" data-start=\"4792\"\u003e\u003cstrong data-end=\"4804\" data-start=\"4795\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e9:35 – 10:20 am\u003c\/p\u003e\n\u003chr data-end=\"4825\" data-start=\"4822\"\u003e\n\u003ch3 data-end=\"4884\" data-start=\"4827\"\u003e\u003cstrong data-end=\"4882\" data-start=\"4831\"\u003eSession V: Triple Negative Breast Cancer (TNBC)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"5583\" data-start=\"4886\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"4966\" data-start=\"4886\"\u003e\n\u003ctr data-end=\"4966\" data-start=\"4886\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"4904\" data-start=\"4886\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"4952\" data-start=\"4904\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"4966\" data-start=\"4952\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5583\" data-start=\"5048\"\u003e\n\u003ctr data-end=\"5133\" data-start=\"5048\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5067\" data-start=\"5048\"\u003e10:35 – 10:55 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5115\" data-start=\"5067\"\u003eSmall TNBCs: How Small Is Small Enough?\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5133\" data-start=\"5115\"\u003eSteven Isakoff\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5262\" data-start=\"5134\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5153\" data-start=\"5134\"\u003e10:55 – 11:15 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5240\" data-start=\"5153\"\u003eAntibody Drug Conjugates in TNBC and Refractory ER Positive Metastatic Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5262\" data-start=\"5240\"\u003eAna Garrido-Castro\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5355\" data-start=\"5263\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5282\" data-start=\"5263\"\u003e11:15 – 11:35 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5330\" data-start=\"5282\"\u003eImmunotherapy in TNBC\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5355\" data-start=\"5330\"\u003eGuilherme Nader Marta\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5441\" data-start=\"5356\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5375\" data-start=\"5356\"\u003e11:35 – 11:55 am\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5426\" data-start=\"5375\"\u003eManaging Endocrine Side Effects of Immunotherapy\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5441\" data-start=\"5426\"\u003eElad Sharon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5583\" data-start=\"5442\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5464\" data-start=\"5442\"\u003e11:55 am – 12:10 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5509\" data-start=\"5464\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5583\" data-start=\"5509\"\u003eSteven Isakoff, Ana Garrido-Castro, Guilherme Nader Marta, Elad Sharon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5588\" data-start=\"5585\"\u003e\n\u003ch3 data-end=\"5635\" data-start=\"5590\"\u003e\u003cstrong data-end=\"5633\" data-start=\"5594\"\u003eTumor Board: Advanced Breast Cancer\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"5855\" data-start=\"5637\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"5669\" data-start=\"5637\"\u003e\n\u003ctr data-end=\"5669\" data-start=\"5637\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5655\" data-start=\"5637\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"lg\" data-end=\"5669\" data-start=\"5655\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5855\" data-start=\"5703\"\u003e\n\u003ctr data-end=\"5855\" data-start=\"5703\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5721\" data-start=\"5703\"\u003e12:20 – 1:30 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"5855\" data-start=\"5721\"\u003eRachel Freedman, Barbara Smith, Sarah Sammons, Erica Mayer, Laura Spring, Leticia Varella, Guilherme Nader Marta, Daniel Abravanel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5860\" data-start=\"5857\"\u003e\n\u003ch3 data-end=\"5909\" data-start=\"5862\"\u003e\u003cstrong data-end=\"5907\" data-start=\"5866\"\u003eSession VI: ER Positive Breast Cancer\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\"\u003e\n\u003ctable data-end=\"6586\" data-start=\"5911\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-end=\"5991\" data-start=\"5911\"\u003e\n\u003ctr data-end=\"5991\" data-start=\"5911\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5929\" data-start=\"5911\"\u003eTime\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5977\" data-start=\"5929\"\u003eSession Title\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5991\" data-start=\"5977\"\u003eSpeaker(s)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6586\" data-start=\"6073\"\u003e\n\u003ctr data-end=\"6158\" data-start=\"6073\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6091\" data-start=\"6073\"\u003e1:40 – 2:00 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6143\" data-start=\"6091\"\u003eNew Approaches in Early ER Positive Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6158\" data-start=\"6143\"\u003eErica Mayer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6265\" data-start=\"6159\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6177\" data-start=\"6159\"\u003e2:00 – 2:20 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6250\" data-start=\"6177\"\u003ePI3K Inhibitors in Metastatic Breast Cancer: Choosing the Right Target\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6265\" data-start=\"6250\"\u003eDejan Juric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6358\" data-start=\"6266\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6284\" data-start=\"6266\"\u003e2:20 – 2:40 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6343\" data-start=\"6284\"\u003eAdvanced ER Positive Breast Cancer: A Surfeit of Choices\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6358\" data-start=\"6343\"\u003eSeth Wander\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6461\" data-start=\"6359\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6377\" data-start=\"6359\"\u003e2:40 – 3:00 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6442\" data-start=\"6377\"\u003eEmerging Antibody Drug Conjugates in ER Positive Breast Cancer\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6461\" data-start=\"6442\"\u003ePaolo Tarantino\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6586\" data-start=\"6462\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6480\" data-start=\"6462\"\u003e3:00 – 3:15 pm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6528\" data-start=\"6480\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6586\" data-start=\"6528\"\u003eErica Mayer, Seth Wander, Paolo Tarantino, Dejan Juric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6591\" data-start=\"6588\"\u003e\n\u003ch3 data-end=\"6640\" data-start=\"6593\"\u003e\u003cstrong data-end=\"6638\" data-start=\"6597\"\u003eCDK4\/6: Which One? For Whom? – Debate\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"6709\" data-start=\"6641\"\u003e\u003cstrong data-end=\"6654\" data-start=\"6641\"\u003eSpeakers:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eShana Berwick, Laura Spring\u003cbr data-end=\"6685\" data-start=\"6682\"\u003e\u003cstrong data-end=\"6694\" data-start=\"6685\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e3:15 – 3:30 pm\u003c\/p\u003e\n\u003chr data-end=\"6714\" data-start=\"6711\"\u003e\n\u003ch3 data-end=\"6741\" data-start=\"6716\"\u003e\u003cstrong data-end=\"6739\" data-start=\"6720\"\u003eASCO Highlights\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"6797\" data-start=\"6742\"\u003e\u003cstrong data-end=\"6754\" data-start=\"6742\"\u003eSpeaker:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eHarold Burstein\u003cbr data-end=\"6773\" data-start=\"6770\"\u003e\u003cstrong data-end=\"6782\" data-start=\"6773\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e3:30 – 4:25 pm\u003c\/p\u003e\n\u003chr data-end=\"6802\" data-start=\"6799\"\u003e\n\u003ch3 data-end=\"6829\" data-start=\"6804\"\u003e\u003cstrong data-end=\"6827\" data-start=\"6808\"\u003eClosing Remarks\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"6885\" data-start=\"6830\"\u003e\u003cstrong data-end=\"6842\" data-start=\"6830\"\u003eSpeaker:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eHarold Burstein\u003cbr data-end=\"6861\" data-start=\"6858\"\u003e\u003cstrong data-end=\"6870\" data-start=\"6861\"\u003eTime:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e4:25 – 4:45 pm\u003cbr\u003e\u003cbr\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0733\/7728\/4236\/files\/harvard-breast-cancer-new-horizons-current-controversies-2025-videos-slides_68f4601b5eb84-510x195.jpg?v=1763762912\" style=\"float: none;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Doctor David","offers":[{"title":"Default Title","offer_id":43222002073663,"sku":null,"price":149.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0653\/0865\/5679\/files\/ChatGPT_Image_Nov_22_2025_03_03_59_AM.png?v=1778025296","url":"https:\/\/www.ebooksmedical.com\/products\/harvard-breast-cancer-new-horizons-current-controversies-2025-videos-slides","provider":"Ebooks Medical","version":"1.0","type":"link"}